NRN1 and glaucoma: NRN1 is uniquely positioned as it can target multiple pathophysiological drivers of glaucoma, including lack of neurotrophic support and aberrant intracellular signaling, ultimately addressing the critical endpoint of glaucoma’s pathophysiological process: the loss of RGCs.